Oligometastatic breast cancer: dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?

In the last years we have witnessed unprecedented improvements of breast cancer (BC)-related survival, mostly driven by the progressive enhancement of the therapeutic armamentarium with increasingly effective treatment strategies[1]. Approximately 20-30% of patients with early-stage disease will eventually experience disease relapse and 5% are diagnosed with de-novo stage IV disease[2,3]. Once metastatic, BC is traditionally considered an incurable condition, where treatment choices, although potentially aimed at prolonging survival, are typically driven by palliative motives.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Hot Topic Source Type: research